Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | GLA | P06280 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CASP1 | P29466 | 2/20 | 0.52 |
| ▸ | CASP7 | P55210 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | NQO2 | P16083 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30148539 | 1.00 | HSD17B10 (0.52) | HSD17B10KDM4EGLAALDH1A1SMN1; SMN2 | |
| SCHEMBL1420724 | 0.94 | NCOA1 (0.47) | HSD17B10KDM4EGLAALDH1A1SMN1; SMN2 | |
| SCHEMBL27550242 | 0.82 | PDE10A (0.55) | HSD17B10KDM4EGLAALDH1A1SMN1; SMN2 | |
| SCHEMBL641899 | 0.82 | PDE10A (0.66) | HSD17B10KDM4EGLAALDH1A1SMN1; SMN2 | |
| SCHEMBL29377848 | 0.82 | PDE10A (0.66) | HSD17B10KDM4EGLAALDH1A1SMN1; SMN2 | |
| SCHEMBL29864783 | 0.81 | PDE10A (0.75) | HSD17B10KDM4EALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL20659212 | 0.81 | PDE10A (0.75) | HSD17B10KDM4EALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL8168011 | 0.81 | PDE10A (0.47) | HSD17B10ALDH1A1HPGDPDE10ATP53 | |
| SCHEMBL3402941 | 0.81 | AKR1B1 (0.47) | HSD17B10KDM4EGLAALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL1603404 | 0.80 | PDE10A (0.63) | HSD17B10KDM4EGLAALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 921 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111886315-B | Sealing material for display element, cured product thereof, frame sealing material for organic EL element, and face sealing material for organic EL element | 三井化学株式会社 | 2023-06-30 | — | — | CN | claimed |
| CN-111886315-A | Sealing material for display element, cured product thereof, frame sealing material for organic EL element, and surface sealing material for organic EL element | 三井化学株式会社 | 2020-11-03 | — | — | CN | claimed |
| US-10641768-B2 | Methods and kits for decreasing interferences from leukocytes in specific binding assays | ABBOTT JAPAN CO. LTD. (JP) | 2020-05-05 | — | — | US | claimed |
| WO-2019181592-A1 | ENCAPSULATING MATERIAL FOR DISPLAY ELEMENT AND CURED PRODUCT THEREOF, FRAME ENCAPSULATING MATERIAL FOR ORGANIC EL ELEMENT, AND SURFACE ENCAPSULATING MATERIAL FOR ORGANIC EL ELEMENT | 三井化学株式会社 | 2019-09-26 | — | — | WO | claimed |
| CN-103764140-B | Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases | 韩国化学研究院 | 2017-05-17 | — | — | CN | claimed |
| CN-103764140-A | Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases | KOREA RES INST CHEM TECH | 2014-04-30 | — | — | CN | claimed |
| US-20140072996-A1 | METHODS AND KITS FOR DETECTING HEMOGLOBIN IN TEST SAMPLES | ABBOTT LABORATORIES (US) | 2014-03-13 | — | — | US | claimed |
| US-8574858-B2 | Autoantibody enhanced immunoassays and kits | ABBOTT LABORATORIES (US) | 2013-11-05 | — | — | US | claimed |
| EP-2598534-A1 | ANTIBODIES RELATING TO PIVKA-II AND USES THEREOF | Abbott Laboratories (US) | 2013-06-05 | — | — | EP | claimed |
| US-20130029353-A1 | AUTOANTIBODY ENHANCED IMMUNOASSAYS AND KITS | ABBOTT LABORATORIES (US) | 2013-01-31 | — | — | US | claimed |
| WO-2008051762-A2 | IMMUNOASSAY OF ANALYTES IN SAMPLES CONTAINING ENDOGENOUS ANTI-ANALYTE ANTIBODIES | ABBOTT LABORATORIES (US) | 2008-05-02 | — | — | WO | claimed |
| WO-2008051761-A2 | ASSAY FOR CARDIAC TROPONIN AUTOANTIBODIES | ABBOTT LABORATORIES (US) | 2008-05-02 | — | — | WO | claimed |
| US-20080102481-A1 | Assay for cardiac troponin autoantibodies | ABBOTT LABORATORIES | 2008-05-01 | — | — | US | claimed |
| US-7329493-B2 | One-tube nested PCR for detecting Mycobacterium tuberculosis | ASIAGEN CORPORATION (TW) | 2008-02-12 | — | — | US | claimed |
| US-20060210966-A1 | Kits and methods for detecting bovine ephemeral fever virus | ASIAGEN CORPORATION | 2006-09-21 | — | — | US | claimed |
| US-20060134648-A1 | One-tube nested PCR for detecting mycobacterium tuberculosis | ASIAGEN CORPORATION | 2006-06-22 | — | — | US | claimed |
| US-20050244835-A1 | Methods, kits and assay system for detecting drug-resistant Mycobacterium tuberculosis | ASIAGEN CORPORATION | 2005-11-03 | — | — | US | claimed |
| US-20050123933-A1 | Assay systems, kits and methods for detecting microorganisms | ASIAGEN CORPORATION | 2005-06-09 | — | — | US | claimed |
| US-20040219564-A1 | DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds | ASIAGEN CORPORATION (TW) | 2004-11-04 | — | — | US | claimed |
| US-20040219538-A1 | DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds | ASIAGEN CORPORATION | 2004-11-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219538-A1 | DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds | DNMT1, ACR, DNMT3A | HSD17B10 1931/4885KDM4E 957/4885GLA 866/4885 |
| US-20060134648-A1 | One-tube nested PCR for detecting mycobacterium tuberculosis | TERT, POLRMT, MRM1 | HSD17B10 2020/4885KDM4E 3236/4885GLA 2167/4885 |
| US-20040219564-A1 | DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds | DNMT1, ACR, DNMT3A | HSD17B10 1931/4885KDM4E 957/4885GLA 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.